论文部分内容阅读
目的:探讨大剂量复方苦参注射液联合小剂量FOLFOX经动脉置管灌注治疗晚期肝癌的疗效。方法:治疗组25例大剂量复方苦参注射液联合小剂量FOLFOX经动脉置管灌注治疗,对照组15例采用保守姑息支持疗法,比较两组的临床疗效,生活质量及不良反应。结果:治疗组临床疗效及疾病相关症状改善明显好于对照组,不良反应无明显差别。结论:大剂量复方苦参注射液联合小剂量FOLFOX经动脉置管灌注治疗晚期肝癌治疗是一种有价值的治疗方法。
Objective: To investigate the curative effect of high dose Compound Kushen Injection combined with small dose of FOLFOX via arterial catheter infusion in the treatment of advanced liver cancer. Methods: Twenty-five high-dose compound Kushen injection combined with low-dose FOLFOX was infused via arterial catheterization in the treatment group. Fifteen patients in the control group were treated with conservative palliative supportive therapy. The clinical efficacy, quality of life and adverse reactions were compared between the two groups. Results: The clinical efficacy and disease-related symptoms in the treatment group were significantly better than those in the control group, with no significant difference in adverse reactions. Conclusion: The high-dose compound Kushen injection combined with low-dose FOLFOX via arterial catheter infusion in the treatment of advanced liver cancer is a valuable treatment.